Concepts (227)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Bariatric Surgery | 13 | 2024 | 200 | 2.260 |
Why?
|
| Obesity, Morbid | 12 | 2024 | 241 | 1.920 |
Why?
|
| Pandemics | 4 | 2020 | 778 | 1.050 |
Why?
|
| Surgery Department, Hospital | 3 | 2020 | 44 | 0.980 |
Why?
|
| Laparoscopy | 9 | 2020 | 780 | 0.910 |
Why?
|
| Esophagectomy | 3 | 2017 | 91 | 0.830 |
Why?
|
| Infection Control | 3 | 2020 | 124 | 0.830 |
Why?
|
| Perioperative Care | 4 | 2019 | 171 | 0.820 |
Why?
|
| Patient Selection | 4 | 2020 | 682 | 0.760 |
Why?
|
| Pneumonia, Viral | 3 | 2020 | 319 | 0.730 |
Why?
|
| Coronavirus Infections | 3 | 2020 | 305 | 0.720 |
Why?
|
| Postoperative Complications | 9 | 2023 | 2314 | 0.680 |
Why?
|
| Disease Transmission, Infectious | 1 | 2020 | 58 | 0.660 |
Why?
|
| Stomach Neoplasms | 7 | 2020 | 288 | 0.660 |
Why?
|
| Health Resources | 1 | 2020 | 80 | 0.660 |
Why?
|
| Weight Loss | 7 | 2023 | 233 | 0.650 |
Why?
|
| Gastric Bypass | 6 | 2017 | 113 | 0.620 |
Why?
|
| Decision Making | 2 | 2020 | 670 | 0.580 |
Why?
|
| Gastrectomy | 4 | 2013 | 71 | 0.570 |
Why?
|
| Smoke | 1 | 2017 | 27 | 0.560 |
Why?
|
| Health Communication | 1 | 2017 | 13 | 0.550 |
Why?
|
| Carbon Monoxide | 1 | 2017 | 93 | 0.550 |
Why?
|
| Clinical Protocols | 1 | 2017 | 158 | 0.530 |
Why?
|
| Endoscopy, Gastrointestinal | 2 | 2008 | 163 | 0.530 |
Why?
|
| Triage | 3 | 2020 | 117 | 0.490 |
Why?
|
| Obesity | 4 | 2017 | 972 | 0.460 |
Why?
|
| Esophageal Neoplasms | 3 | 2020 | 332 | 0.460 |
Why?
|
| Length of Stay | 2 | 2017 | 749 | 0.450 |
Why?
|
| Metabolic Diseases | 2 | 2015 | 50 | 0.450 |
Why?
|
| Thoracic Surgery, Video-Assisted | 1 | 2014 | 30 | 0.450 |
Why?
|
| Malabsorption Syndromes | 2 | 2009 | 21 | 0.420 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2014 | 258 | 0.390 |
Why?
|
| Quality Improvement | 3 | 2023 | 457 | 0.390 |
Why?
|
| Pneumonectomy | 1 | 2014 | 211 | 0.380 |
Why?
|
| Humans | 49 | 2024 | 89961 | 0.360 |
Why?
|
| Robotics | 1 | 2014 | 270 | 0.360 |
Why?
|
| Surgical Stapling | 1 | 2010 | 17 | 0.350 |
Why?
|
| Gastroplasty | 1 | 2010 | 25 | 0.340 |
Why?
|
| Fundoplication | 1 | 2010 | 79 | 0.340 |
Why?
|
| Hospitals | 2 | 2023 | 303 | 0.320 |
Why?
|
| Lung Diseases | 1 | 2011 | 275 | 0.320 |
Why?
|
| Betacoronavirus | 3 | 2020 | 262 | 0.310 |
Why?
|
| Gastroesophageal Reflux | 1 | 2010 | 125 | 0.310 |
Why?
|
| Hospital Mortality | 1 | 2011 | 408 | 0.310 |
Why?
|
| Stomach | 1 | 2008 | 111 | 0.300 |
Why?
|
| Foreign Bodies | 1 | 2008 | 66 | 0.290 |
Why?
|
| Biliopancreatic Diversion | 1 | 2006 | 3 | 0.280 |
Why?
|
| Anticoagulants | 3 | 2020 | 432 | 0.280 |
Why?
|
| Retrospective Studies | 14 | 2024 | 9210 | 0.270 |
Why?
|
| Peutz-Jeghers Syndrome | 1 | 2006 | 9 | 0.270 |
Why?
|
| Intestines | 1 | 2009 | 416 | 0.270 |
Why?
|
| Surgical Wound Infection | 2 | 2019 | 202 | 0.260 |
Why?
|
| Digestive System Surgical Procedures | 3 | 2018 | 128 | 0.260 |
Why?
|
| Venous Thromboembolism | 2 | 2020 | 161 | 0.260 |
Why?
|
| Internet | 2 | 2020 | 323 | 0.260 |
Why?
|
| Middle Aged | 19 | 2024 | 26146 | 0.240 |
Why?
|
| Adenocarcinoma | 4 | 2020 | 1185 | 0.220 |
Why?
|
| Risk Assessment | 4 | 2020 | 2327 | 0.220 |
Why?
|
| Vulnerable Populations | 1 | 2024 | 84 | 0.220 |
Why?
|
| Male | 22 | 2024 | 42674 | 0.210 |
Why?
|
| Treatment Outcome | 10 | 2023 | 8273 | 0.210 |
Why?
|
| Double-Balloon Enteroscopy | 1 | 2021 | 11 | 0.190 |
Why?
|
| Colectomy | 2 | 2020 | 175 | 0.190 |
Why?
|
| Guideline Adherence | 2 | 2020 | 234 | 0.190 |
Why?
|
| Adult | 17 | 2024 | 26816 | 0.180 |
Why?
|
| Intestinal Diseases | 1 | 2021 | 79 | 0.180 |
Why?
|
| Health Services Accessibility | 1 | 2024 | 436 | 0.170 |
Why?
|
| Chemoprevention | 1 | 2020 | 92 | 0.170 |
Why?
|
| Efficiency, Organizational | 1 | 2020 | 59 | 0.170 |
Why?
|
| Female | 20 | 2024 | 46587 | 0.170 |
Why?
|
| Aged | 10 | 2020 | 19254 | 0.160 |
Why?
|
| Patient Care Bundles | 1 | 2019 | 21 | 0.160 |
Why?
|
| Operating Rooms | 1 | 2020 | 125 | 0.160 |
Why?
|
| Elective Surgical Procedures | 1 | 2020 | 129 | 0.160 |
Why?
|
| Glucuronosyltransferase | 1 | 2020 | 186 | 0.160 |
Why?
|
| Risk | 1 | 2020 | 657 | 0.150 |
Why?
|
| Venous Thrombosis | 2 | 2014 | 256 | 0.150 |
Why?
|
| Body Mass Index | 3 | 2017 | 776 | 0.150 |
Why?
|
| Fires | 1 | 2017 | 21 | 0.140 |
Why?
|
| Thinness | 1 | 2017 | 46 | 0.140 |
Why?
|
| Enoxaparin | 1 | 2016 | 23 | 0.140 |
Why?
|
| Hemorrhage | 1 | 2018 | 287 | 0.130 |
Why?
|
| Hyperparathyroidism, Secondary | 1 | 2016 | 69 | 0.130 |
Why?
|
| Mentors | 1 | 2017 | 90 | 0.130 |
Why?
|
| Logistic Models | 3 | 2019 | 1214 | 0.130 |
Why?
|
| Thrombosis | 1 | 2018 | 302 | 0.130 |
Why?
|
| Heparin | 1 | 2016 | 185 | 0.130 |
Why?
|
| Cystectomy | 1 | 2016 | 106 | 0.130 |
Why?
|
| Chicago | 1 | 2020 | 1434 | 0.120 |
Why?
|
| Severity of Illness Index | 2 | 2011 | 1862 | 0.120 |
Why?
|
| Diaphragm | 1 | 2014 | 50 | 0.120 |
Why?
|
| Respiration Disorders | 1 | 2014 | 41 | 0.110 |
Why?
|
| Insulin Resistance | 1 | 2016 | 353 | 0.110 |
Why?
|
| Hospitals, Low-Volume | 1 | 2013 | 19 | 0.110 |
Why?
|
| Circadian Rhythm | 1 | 2016 | 303 | 0.110 |
Why?
|
| Smoking | 1 | 2017 | 625 | 0.110 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2014 | 188 | 0.100 |
Why?
|
| Surgeons | 1 | 2017 | 249 | 0.100 |
Why?
|
| Specialties, Surgical | 1 | 2013 | 66 | 0.100 |
Why?
|
| Prognosis | 4 | 2016 | 3798 | 0.100 |
Why?
|
| Illinois | 3 | 2023 | 485 | 0.100 |
Why?
|
| Analysis of Variance | 2 | 2011 | 899 | 0.100 |
Why?
|
| Carcinoma, Lobular | 1 | 2012 | 81 | 0.100 |
Why?
|
| Practice Guidelines as Topic | 3 | 2019 | 1055 | 0.100 |
Why?
|
| Cadherins | 1 | 2012 | 163 | 0.100 |
Why?
|
| Patient Care Team | 1 | 2014 | 284 | 0.090 |
Why?
|
| Pilot Projects | 1 | 2014 | 872 | 0.090 |
Why?
|
| Heart-Assist Devices | 1 | 2018 | 807 | 0.090 |
Why?
|
| Surgical Staplers | 1 | 2010 | 11 | 0.090 |
Why?
|
| Diverticulum, Esophageal | 1 | 2010 | 6 | 0.090 |
Why?
|
| Internationality | 3 | 2015 | 70 | 0.090 |
Why?
|
| Prospective Studies | 2 | 2019 | 4329 | 0.080 |
Why?
|
| Adolescent | 4 | 2017 | 9340 | 0.080 |
Why?
|
| Chondrodysplasia Punctata | 1 | 2009 | 6 | 0.080 |
Why?
|
| Duodenum | 2 | 2007 | 105 | 0.080 |
Why?
|
| Vitamin K Deficiency | 1 | 2009 | 5 | 0.080 |
Why?
|
| Neoplasm Invasiveness | 1 | 2011 | 569 | 0.080 |
Why?
|
| Models, Biological | 1 | 2016 | 1766 | 0.080 |
Why?
|
| Aged, 80 and over | 3 | 2020 | 6783 | 0.080 |
Why?
|
| Cohort Studies | 2 | 2016 | 2886 | 0.080 |
Why?
|
| Heart Failure | 1 | 2018 | 1253 | 0.080 |
Why?
|
| Multivariate Analysis | 1 | 2011 | 983 | 0.080 |
Why?
|
| Disease-Free Survival | 1 | 2011 | 1169 | 0.080 |
Why?
|
| Genetic Testing | 1 | 2012 | 543 | 0.080 |
Why?
|
| Sex Factors | 1 | 2011 | 1075 | 0.070 |
Why?
|
| Marfan Syndrome | 1 | 2007 | 28 | 0.070 |
Why?
|
| Survival Analysis | 1 | 2011 | 1497 | 0.070 |
Why?
|
| Endoscopy, Digestive System | 1 | 2007 | 69 | 0.070 |
Why?
|
| Vitamin D Deficiency | 1 | 2008 | 104 | 0.070 |
Why?
|
| Hernia, Hiatal | 1 | 2007 | 38 | 0.070 |
Why?
|
| Radiography | 1 | 2008 | 808 | 0.070 |
Why?
|
| Age Factors | 1 | 2011 | 1880 | 0.070 |
Why?
|
| Predictive Value of Tests | 1 | 2011 | 1732 | 0.070 |
Why?
|
| Pregnancy Complications | 1 | 2009 | 344 | 0.070 |
Why?
|
| Comorbidity | 1 | 2010 | 953 | 0.070 |
Why?
|
| Prosthesis Implantation | 1 | 2007 | 129 | 0.060 |
Why?
|
| Vena Cava Filters | 1 | 2007 | 98 | 0.060 |
Why?
|
| Neoplasm Staging | 1 | 2011 | 2000 | 0.060 |
Why?
|
| Device Removal | 1 | 2007 | 168 | 0.060 |
Why?
|
| Positron-Emission Tomography | 2 | 2020 | 338 | 0.060 |
Why?
|
| Pulmonary Embolism | 1 | 2007 | 232 | 0.060 |
Why?
|
| Incidence | 2 | 2020 | 1603 | 0.060 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2012 | 2360 | 0.050 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2006 | 218 | 0.050 |
Why?
|
| Follow-Up Studies | 2 | 2007 | 3678 | 0.050 |
Why?
|
| Benchmarking | 1 | 2023 | 79 | 0.050 |
Why?
|
| Young Adult | 2 | 2017 | 6409 | 0.050 |
Why?
|
| Diagnosis, Differential | 1 | 2006 | 1606 | 0.050 |
Why?
|
| Mutation | 1 | 2012 | 4168 | 0.050 |
Why?
|
| Computer Simulation | 1 | 2005 | 1102 | 0.040 |
Why?
|
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 32 | 0.040 |
Why?
|
| Personal Protective Equipment | 1 | 2020 | 35 | 0.040 |
Why?
|
| Leucovorin | 1 | 2020 | 222 | 0.040 |
Why?
|
| Intestine, Small | 1 | 2021 | 299 | 0.040 |
Why?
|
| Healthcare Disparities | 1 | 2024 | 432 | 0.040 |
Why?
|
| Inpatients | 2 | 2016 | 312 | 0.040 |
Why?
|
| Child | 2 | 2020 | 7240 | 0.040 |
Why?
|
| Postoperative Care | 2 | 2013 | 231 | 0.040 |
Why?
|
| Cross Infection | 1 | 2020 | 151 | 0.040 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2021 | 239 | 0.040 |
Why?
|
| Breast Neoplasms | 1 | 2012 | 3022 | 0.040 |
Why?
|
| Fluorouracil | 1 | 2020 | 549 | 0.040 |
Why?
|
| Cell Cycle | 1 | 2000 | 508 | 0.040 |
Why?
|
| Cell Cycle Proteins | 1 | 2000 | 399 | 0.040 |
Why?
|
| Risk Factors | 3 | 2017 | 5558 | 0.030 |
Why?
|
| CLOCK Proteins | 1 | 2016 | 15 | 0.030 |
Why?
|
| Personal Satisfaction | 1 | 2017 | 64 | 0.030 |
Why?
|
| Carrier Proteins | 1 | 2000 | 678 | 0.030 |
Why?
|
| Interprofessional Relations | 1 | 2017 | 121 | 0.030 |
Why?
|
| Overweight | 1 | 2017 | 119 | 0.030 |
Why?
|
| Sweden | 1 | 2015 | 40 | 0.030 |
Why?
|
| Cooperative Behavior | 1 | 2017 | 179 | 0.030 |
Why?
|
| Body Weight | 1 | 2017 | 453 | 0.030 |
Why?
|
| Program Evaluation | 1 | 2017 | 312 | 0.030 |
Why?
|
| Blood Transfusion | 1 | 2016 | 171 | 0.030 |
Why?
|
| Genotype | 1 | 2020 | 1852 | 0.030 |
Why?
|
| Preoperative Care | 2 | 2008 | 395 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2020 | 1730 | 0.030 |
Why?
|
| Robotic Surgical Procedures | 1 | 2020 | 319 | 0.030 |
Why?
|
| DNA-Binding Proteins | 1 | 2000 | 1243 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2017 | 866 | 0.030 |
Why?
|
| Gastrointestinal Stromal Tumors | 1 | 2012 | 23 | 0.030 |
Why?
|
| Gastric Mucosa | 1 | 2012 | 68 | 0.030 |
Why?
|
| Treatment Failure | 1 | 2012 | 278 | 0.020 |
Why?
|
| Lymphatic Metastasis | 1 | 2014 | 495 | 0.020 |
Why?
|
| Societies, Medical | 1 | 2015 | 584 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2000 | 1664 | 0.020 |
Why?
|
| Lymph Node Excision | 1 | 2013 | 220 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2000 | 1983 | 0.020 |
Why?
|
| Antigens, CD | 1 | 2012 | 466 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2014 | 2677 | 0.020 |
Why?
|
| Family | 1 | 2012 | 324 | 0.020 |
Why?
|
| Disease Management | 1 | 2012 | 327 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2014 | 1704 | 0.020 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2020 | 2506 | 0.020 |
Why?
|
| Pregnancy, High-Risk | 1 | 2009 | 16 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2017 | 2655 | 0.020 |
Why?
|
| Indiana | 1 | 2008 | 14 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2020 | 2331 | 0.020 |
Why?
|
| Fatal Outcome | 1 | 2009 | 296 | 0.020 |
Why?
|
| Gastroscopy | 1 | 2007 | 25 | 0.020 |
Why?
|
| Abnormalities, Multiple | 1 | 2009 | 234 | 0.020 |
Why?
|
| United States | 1 | 2020 | 7108 | 0.020 |
Why?
|
| Aortic Rupture | 1 | 2007 | 57 | 0.020 |
Why?
|
| Esophagoscopy | 1 | 2007 | 90 | 0.020 |
Why?
|
| Posture | 1 | 2006 | 125 | 0.020 |
Why?
|
| Radiography, Interventional | 1 | 2007 | 157 | 0.020 |
Why?
|
| Prosthesis Design | 1 | 2007 | 299 | 0.020 |
Why?
|
| Intraoperative Care | 1 | 2006 | 85 | 0.020 |
Why?
|
| Ambulatory Surgical Procedures | 1 | 2006 | 74 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2007 | 785 | 0.010 |
Why?
|
| Terminology as Topic | 1 | 2006 | 222 | 0.010 |
Why?
|
| Prevalence | 1 | 2008 | 1250 | 0.010 |
Why?
|
| Evidence-Based Medicine | 1 | 2006 | 435 | 0.010 |
Why?
|
| Educational Measurement | 1 | 2005 | 231 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2009 | 2497 | 0.010 |
Why?
|
| Models, Theoretical | 1 | 2005 | 493 | 0.010 |
Why?
|
| Pregnancy | 1 | 2009 | 3046 | 0.010 |
Why?
|
| Oxygen | 1 | 2006 | 745 | 0.010 |
Why?
|
| Education, Medical, Graduate | 1 | 2005 | 402 | 0.010 |
Why?
|
| Retinoblastoma-Binding Protein 1 | 1 | 2000 | 10 | 0.010 |
Why?
|
| E2F Transcription Factors | 1 | 2000 | 19 | 0.010 |
Why?
|
| S Phase | 1 | 2000 | 63 | 0.010 |
Why?
|
| Clinical Competence | 1 | 2005 | 796 | 0.010 |
Why?
|
| Time Factors | 1 | 2007 | 5358 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2000 | 2887 | 0.010 |
Why?
|
| Animals | 1 | 2000 | 27528 | 0.000 |
Why?
|